EMBL-CRG Systems Biology Unit, Centre for Genomic Regulation (CRG), the Barcelona Institute of Science and Technology, 08003 Barcelona, Spain; Universitat Pompeu Fabra (UPF), 08003 Barcelona, Spain; Division of Electronics, Rudjer Boskovic Institute, 10000 Zagreb, Croatia.
EMBL-CRG Systems Biology Unit, Centre for Genomic Regulation (CRG), the Barcelona Institute of Science and Technology, 08003 Barcelona, Spain; Universitat Pompeu Fabra (UPF), 08003 Barcelona, Spain; Institució Catalana de Recerca i Estudis Avançats (ICREA), 08010 Barcelona, Spain.
Cell. 2017 Jul 27;170(3):534-547.e23. doi: 10.1016/j.cell.2017.07.003.
Many processes can cause the same nucleotide change in a genome, making the identification of the mechanisms causing mutations a difficult challenge. Here, we show that clustered mutations provide a more precise fingerprint of mutagenic processes. Of nine clustered mutation signatures identified from >1,000 tumor genomes, three relate to variable APOBEC activity and three are associated with tobacco smoking. An additional signature matches the spectrum of translesion DNA polymerase eta (POLH). In lymphoid cells, these mutations target promoters, consistent with AID-initiated somatic hypermutation. In solid tumors, however, they are associated with UV exposure and alcohol consumption and target the H3K36me3 chromatin of active genes in a mismatch repair (MMR)-dependent manner. These regions normally have a low mutation rate because error-free MMR also targets H3K36me3 chromatin. Carcinogens and error-prone repair therefore redistribute mutations to the more important regions of the genome, contributing a substantial mutation load in many tumors, including driver mutations.
许多过程都可能导致基因组中的同一核苷酸发生变化,因此,确定导致突变的机制是一项艰巨的挑战。在这里,我们表明,聚集的突变为诱变过程提供了更精确的指纹。在从>1000 个肿瘤基因组中鉴定出的 9 个聚集突变特征中,有 3 个与 APOBEC 活性的可变性有关,有 3 个与吸烟有关。另一个特征与跨损伤 DNA 聚合酶 eta(POLH)的谱相匹配。在淋巴细胞中,这些突变靶向启动子,与 AID 引发的体细胞超突变一致。然而,在实体瘤中,它们与紫外线照射和饮酒有关,并以依赖于错配修复(MMR)的方式靶向 H3K36me3 染色质的活性基因。这些区域通常突变率较低,因为无差错的 MMR 也靶向 H3K36me3 染色质。因此,致癌物和易错修复将突变重新分配到基因组中更重要的区域,在许多肿瘤中,包括驱动突变,都导致了大量的突变负荷。